Published August 3, 2026 · Category: News

Overview

The popular and experimental drugs called peptides received unprecedented attention last month during a marathon hearing held by a panel that advises the Food and Drug Administration.

An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.

Details

(Image credit: Catherine Falls Commercial)

Source

Originally published at www.npr.org.

Related Articles